Document is current

Article History

Received: 26 November 2024

Accepted: 28 July 2025

First Online: 30 August 2025

Declarations

:

: In accordance with the Declaration of Helsinki, the study was reviewed and approved by the Yale Institutional Review Board which served as Central Institutional Review Board for the study. Written informed consent was provided by the participants’ legal guardian; assent was provided by the child participant. While not a clinical trial, the study was registered with ClinicalTrials.gov (NCT02996669).

: Not applicable.

: Geraldine Dawson is on the Scientific Advisory Boards of Tris Pharma and the Nonverbal Learning Disability Project, a consultant for Apple, Inc, and receives book royalties from Guilford Press, Springer, and Oxford University Press. Shafali Jeste is a consultant for Roche Pharmaceutical Company. James C. McPartland consults or has consulted with Customer Value Partners, Bridgebio, Determined Health, Apple, and BlackThorn Therapeutics, has received research funding from Janssen Research and Development, serves on the Scientific Advisory Boards of Pastorus and Modern Clinics, and receives royalties from Guilford Press, Lambert, Oxford, and Springer. Frederick Shic is a consultant for Roche Pharmaceutical Company and Janssen Research.All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interest.